News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AngioChem to Present at the American Society of Human Genetics 2013 Annual Meeting



10/17/2013 6:48:35 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced that an abstract on its Angiopep-2 (An2) conjugate technology has been selected for presentation at the American Society of Human Genetics (ASHG) 2013 Annual Meeting being held October 22-26, 2013 in Boston, Massachusetts.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES